Covid19 Vaccine
Covid19 Vaccine News
Health
WHO clears Novavax as 10th authorised COVID-19 jab: From efficacy to side-effects, all you need to know about vaccine
Nuvaxovid, made from a more conventional technology than others already approved, is likely to help persuade those hesitant about vaccination to come forward
Science behind Vaccines: You don’t need to worry about COVID vaccines being ‘unnatural’ or ‘synthetic’
The mRNA vaccines are the first synthetic vaccines and it is a temporary genetic instruction that tells our cells to make a particular protein.
Centre allows foreign nationals to register for COVID-19 vaccine on CoWin portal; check details here
The beneficiaries would need to be registered on the CoWin portal and they can do so by using their passport as an identity document for registration
COVID-19 news: Third wave unlikely to impact children more, claims AIIMS-WHO study; India logs 67,208 cases
The US Centers for Disease Control and Prevention has classified the Delta, a highly transmissible COVID-19 variant first identified in India, as a “variant of concern”
COVID-19 news update: Centre defends increasing gap between doses; report claims 'underreporting' of deaths in Chennai
On the vaccine front, India's vaccination drive seemed set to get another push with SII announcing that it hopes to launch Novavax’s COVID-19 vaccine ‘Covovax’ in India by September
RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year
The first batch of the COVID-19 vaccine produced at Panacea Biotec's facilities at Baddi in Himachal Pradesh will be shipped to Russia's Gamaleya Center for quality control
Discussions on with Indian govt for expedited approval of COVID-19 vaccine, says Pfizer
CEO Albert Bourla said that Pfizer is aware that 'access to vaccines is critical'. "Unfortunately, our vaccine is not registered in India although our application was submitted months ago," the CEO added
COVID-19 vaccine data analysis: At current rate of 2.2mn doses per day, India can only cover 30% population by end-2021
Free universal vaccination across classes and regions may be the only way to ensure maximum coverage
COVID-19 vaccine: Bharat Biotech to boost Covaxin production to 700 million doses per year
According to a press release issued by the Hyderabad-based vaccine maker, manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore
WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
The UN body has also sought a meeting with the Drugs Controller General of India to discuss the matter 10:12
COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies
Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement
AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues
The revised figures comes a day after an independent panel in the US accused AstraZeneca of cherry-picking data in determining the protection offered by its vaccine
Hong Kong, Macau suspend use of Pfizer-BioNTech COVID-19 vaccine over defective lids
Hong Kong govt has said the suspension was immediate while the matter is investigated by distributor Fosun Pharma and BioNTech, the German company that created the vaccine with American pharmaceutical firm Pfizer
Over 3.25 million vaccine doses administered on 22 March, highest single-day vaccination so far, says Centre
Out of these, 29,03,030 beneficiaries were vaccinated across 48,345 sessions for the first dose and 3,50,065 healthcare workers (HCWs) and frontline workers (FLWs) received the second dose of vaccine
Moderna kicks off COVID-19 vaccine trials in children aged 6 months to under 12 years
"This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population," said CEO Stephane Bancel in a statement
China to issue visas to foreigners, including Indians, if they have taken Chinese COVID-19 vaccine
The embassy statement said the new rule applied to those who had either had two doses of the vaccine or a single-dose at least 14 days before applying for the visa
Germany approves AstraZeneca COVID-19 vaccine for citizens over 65 years of age
The country had previously cited lack of sufficient data to greenlight the vaccine for older people
Coronavirus News Updates: Glitches, OTP delays reported on Day 1 of vaccine rollout; President Kovind, PM, Amit Shah take first dose of Covaxin
Coronavirus News LIVE Updates: India launched phase 3 of its Covid-19 vaccination drive on Monday benefiting everyone above the age of 60 and those within the age bracket of 45-59 with comorbidities to get vaccinated
Phase 2 of COVID-19 vaccination drive: Narendra Modi takes first dose of Covaxin; CoWin glitches, delays mark rollout
India's coronavirus case count went past 1.11 crore on Monday with 15,510 new infections, while the active cases registered an increase for the fifth consecutive day
UK'S COVID-19 vaccine rollout enters new phase, expands to inoculate those above 60 years
Almost 2 million people aged 60 to 63 will be invited from Monday, with letters explaining how they can make an appointment for the jab